<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36062113</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Characteristics of Long-COVID care centers in Italy. A national survey of 124 clinical sites.</ArticleTitle><Pagination><StartPage>975527</StartPage><MedlinePgn>975527</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">975527</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2022.975527</ELocationID><Abstract><AbstractText Label="BACKGROUND">Despite the growing clinical relevance of Long-COVID, there is minimal information available on the organizational response of health services to this condition.</AbstractText><AbstractText Label="METHODS">A national online survey of centers providing assistance for Long-COVID was implemented. Information collected included date of start of activity, target population, mode of assistance and of referral, type and number of specialists available, diagnostic and instrumental tests, use of telemedicine and of specific questionnaires.</AbstractText><AbstractText Label="RESULTS">Between February and May 2022, 124 centers completed the survey. Half of them were situated in northern Italy. Most (88.9%) provided assistance through either outpatient visits or day hospital services. Eleven (8.9%) assisted pediatric patients. Access to centers included scheduled visits for previously hospitalized patients (67.7%), referral from primary care (62.1%), from other specialists (46.8%), and, less commonly, from other services. Almost half of the centers (46.3%) started their activity early in the pandemics (March-September 2020). Almost all (93.5%) communicated with primary care physicians, and 21.8% used telemedicine tools. The mean number of patients followed was 40 per month (median 20, IQR 10-40). In most cases, the center coordinator was a specialist in respiratory diseases (30.6%), infectious diseases (28.2%), or internal medicine (25.0%). At least half of the centers had specialistic support in cardiology, respiratory diseases, radiology, infectious diseases, neurology and psychology, but roughly one quarter of centers had just only one (14.5%) or two (9.7%) specialists available. The clinical assessment was usually supported by a wide range of laboratory and instrumental diagnostics and by multidimensional evaluations.</AbstractText><AbstractText Label="CONCLUSIONS">Most of the centers had an articulate and multidisciplinary approach to diagnosis and care of Long-COVID. However, a minority of centers provided only single or dual specialistic support. These findings may be of help in defining common standards, interventions and guidelines that can reduce gaps and heterogeneity in assistance to patients with Long-COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Floridia, Grassi, Giuliano, Tiple, Pricci, Villa, Silenzi and Onder.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Floridia</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Center for Global Health, Istituto Superiore di Sanit&#xe0;, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grassi</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanit&#xe0;, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giuliano</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Center for Global Health, Istituto Superiore di Sanit&#xe0;, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiple</LastName><ForeName>Dorina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Istituto Superiore di Sanit&#xe0;, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pricci</LastName><ForeName>Flavia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanit&#xe0;, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villa</LastName><ForeName>Marika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanit&#xe0;, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silenzi</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ministry of Health, General Directorate for Health Prevention, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onder</LastName><ForeName>Graziano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanit&#xe0;, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID</Keyword><Keyword MajorTopicYN="N">health care</Keyword><Keyword MajorTopicYN="N">health services</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>5</Day><Hour>4</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36062113</ArticleId><ArticleId IdType="pmc">PMC9437305</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2022.975527</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO . Weekly Epidemiological Update on COVID-19. (2022). Available online at: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19-&#x2212;11-may-2022 (accessed May 13, 2022).</Citation></Reference><Reference><Citation>European Observatory on Health Systems policies . In the wake of the pandemic: preparing for Long COVID. (2021). Available online at: https://eurohealthobservatory.who.int/publications/i/in-the-wake-of-the-pandemic-preparing-for-long-covid-(2021) (accessed June 14, 2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">33877759</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Moschopoulos CD, Margalit I, Gkrania-Klotsas E, Landi F, Stahl J-P, et al. . ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect. (2022) S1198&#x2013;743X (22)00092-1. 10.1016/j.cmi.2022.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis. (2022) jiac136. 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA., Fawzy NA, Abou Shaar B, Almamlouk R, Riaz M, et al. . Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. (2022) 28:657&#x2013;66. 10.1016/j.cmi.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Rebecca Jane Cox RJ, Langeland N. Long COVID: a growing problem in need of intervention. Cell Rep Med. (2022) 3:100552. 10.1016/j.xcrm.2022.100552</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100552</ArticleId><ArticleId IdType="pmc">PMC8841141</ArticleId><ArticleId IdType="pubmed">35474749</ArticleId></ArticleIdList></Reference><Reference><Citation>Staffolani S, Iencinella V, Cimatti M, Tavio M. Long COVID-19 syndrome as a fourth phase of SARS-CoV-2 infection. Infez Med. (2022) 30:22&#x2013;9. 10.53854/liim-3001-3</Citation><ArticleIdList><ArticleId IdType="doi">10.53854/liim-3001-3</ArticleId><ArticleId IdType="pmc">PMC8929740</ArticleId><ArticleId IdType="pubmed">35350258</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli Against COVID-19 Post-Acute Care Study Group . Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res. (2020) 32:1613&#x2013;20. 10.1007/s40520-020-01616-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01616-x</ArticleId><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiash H, Khodor M, Shah J, Ghozy S, Sheble A, Hassan A, et al. . Integrated multidisciplinary post-COVID-19 care in Egypt. Lancet Glob Health. (2021) 9:e908&#x2013;e909. 10.1016/S2214-109X(21)00206-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(21)00206-0</ArticleId><ArticleId IdType="pmc">PMC8131059</ArticleId><ArticleId IdType="pubmed">34019842</ArticleId></ArticleIdList></Reference><Reference><Citation>Santhosh L, Block B, Kim SY, Raju S, Shah RJ, Thakur N, et al. . Rapid design and implementation of post-COVID-19 clinic. Chest. (2021) 160: 671&#x2013;7. 10.1016/j.chest.2021.03.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.03.044</ArticleId><ArticleId IdType="pmc">PMC8010340</ArticleId><ArticleId IdType="pubmed">33811910</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health Care Excellence . NICE guideline NG188: COVID-19 rapid guideline: managing the long-term effects of COVID-19. (2022). Available online at: https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742 (accessed June 7, 2022).</Citation></Reference><Reference><Citation>Centers for Disease Control Prevention. Interim Guidance on Evaluating and Caring for Patients with Post-COVID Conditions.  (2021). Available online at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-index.html (accessed June 7, 2022).</Citation></Reference><Reference><Citation>Sivan M, Greenhalgh T, Darbyshire JL, Mir G, O'Connor RJ, Dawes H, et al. . LOng COVID Multidisciplinary consortium Optimising Treatments and servIces acrOss the NHS (LOCOMOTION): protocol for a mixed-methods study in the UK. BMJ Open. (2022) 12:e063505. 10.1136/bmjopen-2022-063505</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-063505</ArticleId><ArticleId IdType="pmc">PMC9114312</ArticleId><ArticleId IdType="pubmed">35580970</ArticleId></ArticleIdList></Reference><Reference><Citation>Istituto Superiore di Sanit&#xe0; . Interim Guidance on Long-COVID Management Principles. (2021). Available online at: https://www.iss.it/documents/20126/0/Rapporto+ISS+COVID-19+n.15_2021_EN.pdf/dd962ad9-fa53-73dd-7759-55cb5c167675?t=1627575304593 (accessed June 7, 2022).</Citation></Reference><Reference><Citation>World Health Organization . Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID-19 CRF). (2021). Available online at: https://www.who.int/publications/i/item/global-covid-19-clinical-platform-case-report-form-(crf)-for-post-covid-conditions-(post-covid-19-crf-) (accessed July 12, 2022). </Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>